This site is intended for health professionals only
Monday 27 May 2019
Share |

Topic: European Conferences and Symposia

February 19, 2018
New data from VOYAGE 2 trial shows high efficacy response rates were achieved with continuous guselkumab treatment versus withdrawal

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving Tremfya® (guselkumab), who achieved at least a 90% improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.1

 

February 9, 2018
More than 500 people attended the German Hospital Pharmacists Association (ADKA) congress in Würzburg in 2017. Topics included computerised prescribing, advanced therapy medicinal products and landmark clinical papers
“Don’t allow a situation to develop in which doctors think you have a bad [electronic prescribing] system – negative associations tend to persist”, Steffen Härterich (Pharmacy Department, University Hospital of Hamburg-Eppendorf) advised. Dr Härterich has been responsible for the introduction of electronic prescribing in a hospital that already made use of electronic systems for stock control and patient records and wished to implement systems to deal with prescribing, decision support and medication safety.
 
February 9, 2018
A variety of measures can improve the safety of medicines including using standardised injectable magnesium sulphate, flushing of intravenous lines and implementing global coding, symposium participants heard
Alan Wilkinson
Alan Wilkinson
 
Clare Howard
Clare Howard
 
February 8, 2018
Heart disease patients should seek medical advice before adopting a very low calorie diet

Crash diets can cause a transient deterioration in heart function, according to research presented at CMR 2018.1 Patients with heart disease should seek medical advice before adopting a very low calorie diet.
 

Crash diets, also called meal replacement programmes, have become increasingly fashionable in the past few years,” said lead author Dr Jennifer Rayner, clinical research fellow, Oxford Centre for Magnetic Resonance, University of Oxford, Oxford, UK.
 

November 30, 2017
Ann Page and Mark Borthwick will be co-Chairs of UKCPA for two years

At the UKCPA Conference on Saturday 25 November it was announced that Ann Page and Mark Borthwick will be co-Chairs of UKCPA for two years from 1 January 2018.


Mr Borthwick held the post of Chair from 2013 to 2015 and was supported by Ms Page as Vice-Chair during this time. Since May 2015 Ms Page has led the association as Chair, and Mr Borthwick has continued his involvement in the strategic direction of UKCPA as Immediate Past Chair.
 

November 23, 2016
More than 500 pharmacists gathered in Aachen for the German Society for Hospital Pharmacists (ADKA) Congress to explore aspects of medication management and pharmaceutical care at the interfaces in healthcare

More than 500 pharmacists gathered in Aachen for the German Society for Hospital Pharmacists (ADKA) Congress to explore aspects of medication management and pharmaceutical care at the interfaces in healthcare

 

 

October 20, 2016
Sentinel lymph node biopsy using LYMPHOSEEK in patients with oral cavity squamous cell carcinoma

Norgine B.V. presented new data from a phase III study* showing that Lymphoseek®(99mTc-tilmanocept) used with sentinel lymph node biopsy, could be an alternative to the current standard of care in oral cavity squamous cell carcinoma. Sentinel lymph node biopsy is a simple procedure to remove and examine the first nodes where cancer cells may be present. These data were presented at the European Association of Nuclear Medicine (EANM) 2016, Spain.2

 

August 10, 2016
An international panel of distinguished experts gathered to discuss innovations in anticoagulation care, at a symposium hosted by Boehringer Ingelheim during the 2016 EAHP Congress in Vienna, Austria

An international panel of distinguished experts gathered to discuss innovations in anticoagulation care, at a symposium hosted by Boehringer Ingelheim during the 2016 EAHP Congress in Vienna, Austria

 

August 10, 2016
More than 3500 people from 73 countries gathered in Vienna for the 21st EAHP Congress. Key topics included advanced therapy medicinal products, interchangeability of biosimilars and new roles for pharmacy staff

More than 3500 people from 73 countries gathered in Vienna for the 21st EAHP Congress. Key topics included advanced therapy medicinal products, interchangeability of biosimilars and new roles for pharmacy staff

 

 

August 10, 2016
Issues of stability of ready-to-use systemic anticancer drugs were discussed by a distinguished faculty at an illuminating and well-attended satellite symposium sponsored by Sandoz during ECOP 2016 in Dubrovnik, Croatia

Issues of stability of ready-to-use systemic anticancer drugs were discussed by a distinguished faculty at an illuminating and well-attended satellite symposium sponsored by Sandoz during ECOP 2016 in Dubrovnik, Croatia

 

 

May 24, 2016
Dose banding was the topic of discussion at a stimulating satellite symposium sponsored by Sun Pharma, which featured a distinguished faculty from the UK, France and Germany, at the recent EAHP conference in Vienna

Dose banding was the topic of discussion at a stimulating satellite symposium sponsored by Sun Pharma, which featured a distinguished faculty from the UK, France and Germany, at the recent EAHP conference in Vienna

 

May 24, 2016
More than 700 pharmacists attended the 44th ESCP Symposium in Lisbon where key topics included communicating information about risks, technology appraisal, pharmacoeconomics and implementation science

More than 700 pharmacists attended the 44th ESCP Symposium in Lisbon where key topics included communicating information about risks, technology appraisal, pharmacoeconomics and implementation science

 

 

May 24, 2016
More than 450 pharmacists shared their experiences of compounding problems, risk assessment, environmental contamination and new developments at the recent GERPAC conference

More than 450 pharmacists shared their experiences of compounding problems, risk assessment, environmental contamination and new developments at the recent GERPAC conference

 

 

January 18, 2016
C-level leaders from GSK, Novartis and Lilly have recently aligned in an effort to set out a new minimum standard or performance from their respective companies

C-level leaders from GSK, Novartis and Lilly have recently aligned in an effort to set out a new minimum standard or performance from their respective companies. They will announce their intentions at the eyeforpharma Barcelona Summit where a ‘new business plan’ for the industry comprising collaboration, culture and customer-centricity will be proposed.

 

Speaking ahead of the conference, David Epstein, CEO Pharmaceuticals, Novartis stressed a personal commitment:

 

December 21, 2015
KEYNOTE-010 published in the Lancet and to be presented at the European Society for Medical Oncology (ESMO) Asia 2015 Congress

November 13, 2015
European Committee on Infection Control (EUCIC) is recruiting representatives from European countries to create national committees

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores the risks and best practices in infectious disease – takes the opportunity ahead of the European Antibiotic Awareness Day (EAAD) on 18 November to highlight two of the society’s more recent projects in the fight against antimicrobial resistance.
 

 

October 9, 2015
During the 24th Congress of the European Academy of Dermatology and Venereology (EADV), the International Alliance of Dermatology Patient Organizations (IADPO) announced its official launch at the Patient Village of the Congress

During the 24th Congress of the European Academy of Dermatology and Venereology (EADV), the International Alliance of Dermatology Patient Organizations (IADPO) announced its official launch at the Patient Village of the Congress.

 

October 2, 2015
The first ever international overview of the extent of the advanced and specialised roles that pharmacists are undertaking was presented at the World Congress of Pharmacy and Pharmaceutical Sciences

The first ever international overview of the extent of the advanced and specialised roles that pharmacists are undertaking, and the mechanisms supporting these developments, was presented at the World Congress of Pharmacy and Pharmaceutical Sciences. The information is contained in a new report, “Advanced practice and specialisation in pharmacy: Global report”, produced by the International Pharmaceutical Federation Education Initiative (FIPEd).

 

September 30, 2015
The number of pharmacists per 10,000 population has grown around the world, according to a new report from the International Pharmaceutical Federation Education Initiative (FIPEd)

The publication, “Global pharmacy workforce intelligence: Trends report”, was released at the 75th World Congress of Pharmacy and Pharmaceutical Sciences. It is the fourth in a series of workforce reports produced every three years and contains a trend analysis of the three previous reports (2006, 2009, 2012), which covers 51 countries.
 

 

September 30, 2015
Additional clinical outcomes from large patient registry confirm accuracy of Oncotype DX test in guiding treatment decisions
August 10, 2015
More than 3500 participants from 74 countries gathered in Hamburg in March for the 20th Congress of EAHP. Key themes included medication safety, biosimilars, women's health issues and learning from the nuclear power industry

 

August 10, 2015
Nearly 700 participants gathered in Copenhagen for the European Society of Clinical Pharmacy Symposium. Topics included antibiotic resistance, person-centred risk management plans and medication safety for housebound patients

 

June 10, 2015
Merck Sharp & Dohme (MSD), known as Merck in the United States and Canada, announced additional data from a subanalysis (1) of the multicentre, randomised, double-blind, placebo-controlled GO-AHEAD study on the effect of SIMPONI® (golimumab) in treating patients with non-radiographic axial spondyloarthritis (nr-axial SpA). (2)

Merck Sharp & Dohme (MSD), known as Merck in the United States and Canada, announced additional data from a subanalysis (1) of the multicentre, randomised, double-blind, placebo-controlled GO-AHEAD study on the effect of SIMPONI® (golimumab) in treating patients with non-radiographic axial spondyloarthritis (nr-axial SpA). (2)
 

June 10, 2015
The comparable safety and efficacy of switching patients to a biosimilar anti-TNF-alpha monoclonal antibody from the reference medicinal product (RMP) has been further established in data presented at EULAR 2015, the annual meeting of the European League Against Rheumatism. Data from abstracts published or presented at the conference show that the effectiveness of biosimilar infliximab CT-P13, developed and manufactured by Celltrion, Inc., was similar to the RMP in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients who were switched from the RMP to the biosimilar infliximab, with no additional safety signals. (1)

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine